Skip to main content
. 2021 May 19;8:2333794X211010729. doi: 10.1177/2333794X211010729

Table 1.

Demographics.

Demographics
Study cohort N = 353 Excluded cohort (Infants with HUS performed DOL 0-2) N = 230 P value
Birth gestational age, weeks (mean, SD) 28.89 (2.02) 26.82 (2.45) <.0001
 23 weeks (n, %) 3 (0.8) 18 (7.8) <.00001
 24 weeks (n, %) 13 (3.7) 30 (13.0) <.00001
 25 weeks (n, %) 13 (3.7) 27 (11.7) .0002
 26 weeks (n, %) 17 (4.8) 39 (17.0) <.00001
 27 weeks (n, %) 33 (9.3) 24 (10.4) .666
 28 weeks (n, %) 45 (12.7) 25 (10.9) .495
 29 weeks (n, %) 62 (17.6) 28 (12.2) .078
 30 weeks (n, %) 88 (24.9) 18 (7.8) <.00001
 31 weeks (n, %) 66 (18.7) 16 (7.0) .0001
 32 weeks (n, %) 13 (3.7) 4 (1.7) .173
Birth weight, grams (mean, SD) 1214.54 (323.82) 967.80 (348.39) <.0001
Male/Total (n, %) 194 (55.0) 123 (53.5) .726
Race (n, %): .030
 Black 47 (13.3) 46 (20.0)
 White 284 (80.5) 168 (73.0)
 Asian 14 (4.0) 5 (2.2)
 Other 8 (2.3) 11 (4.8)
Rate of antenatal steroids (n, %) 332 (94.1) 205 (89.1) .031
Bacterial sepsis, on or before DOL3 (n, %) 3 (0.8) 3 (1.3) .595
Sepsis or meningitis, late after DOL3 (n, %)
 Bacterial (n, %) 10 (2.8) 30 (13.0) <.00001
 Coagulase negative staph (n, %) 6 (1.7) 7 (3.0) .283
 Fungal (n, %) 1 (0.3) 2 (0.9) .333
Any respiratory support at 36 weeks (Chronic Lung disease) (n, %) 67 (19.0) 98 (42.6) <.00001
 Mechanical ventilation 3 (0.8) 7 (3.0) .046
 High frequency oscillatory ventilation 1 (0.3) 0 .419
 High flow nasal canula 18 (5.1) 47 (20.4) <.00001
 Noninvasive positive pressure ventilation 5 (1.4) 8 (3.5) .099
 Continuous positive airway pressure 8 (2.3) 6 (2.6) .792
Oxygen at discharge 31 (8.8) 48 (20.9) <.00001
Steroids for chronic lung disease (n, %) 28 (7.9) 58 (25.2) <.00001
Necrotizing enterocolitis (NEC) (n, %) 20 (5.7) 19 (8.3) .220
Surgery for NEC, suspected NEC, or bowel perforation (n, %) 5 (1.4) 10 (4.3) .029
Hypoxic-ischemic encephalopathy (n, %) 0 0